- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06307496
VIDÉOS pour arrêter de fumer
Interventions vidéo pour la dépendance au tabac (VIDeOS) chez les patients cancéreux : une étude pilote contrôlée randomisée
The purpose of the current study is to pilot the efficacy, feasibility, and acceptability of an evidence-based smoking cessation intervention adapted for cancer patients and delivered via video. Investigators aim to assess if this intervention is considered acceptable by participants, feasible to implement, and effective at increasing knowledge about smoking cessation before conducting a fully powered clinical trial.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
A randomized controlled pilot study is being conducted to test the acceptability and feasibility of a smoking cessation intervention tailored for cancer patients that is delivered via video. Participants will be in a video intervention or control group that receives information about quitting smoking. Participants will complete surveys prior to randomization, and will complete additional surveys one week, one month, and three months post-randomization to provide their thoughts about the videos, information about changes to smoking behaviors, and knowledge about quitting smoking.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
South Carolina
-
Charleston, South Carolina, États-Unis, 29425
- Medical University of South Carolina
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 18 or older
- Diagnosed with cancer (any type)
- Receiving care at Medical University of South Carolina
- Reads and understands English language
- Currently smoking cigarettes (any amount)
Exclusion Criteria:
- Unstable or poorly managed medical or psychiatric conditions that impair cognition and ability to provide informed consent (e.g., dementia, active psychosis).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Videos
Participants will be sent links to smoking cessation videos to watch. |
Receive links to smoking cessation videos |
|
Comparateur actif: NCI Pamphlet
Participants will be sent links to NCI's "Clearing the Air" to read. |
Receive NCI's "Clearing the Air" booklet |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Acceptability of Intervention Measure
Délai: 1 week post-randomization
|
Acceptability will be measured using the measure titled the "Acceptability of Intervention Measure" (AIM), which contains four items with answer options on a scale from 1-5. Higher scores indicating higher acceptability. We will consider the intervention "acceptable" if an average score of 4 or higher is obtained. |
1 week post-randomization
|
|
Feasibility of Intervention Measure
Délai: 1 week post-randomization
|
Feasibility will be measured using the measure title the "Feasibility of Intervention Measure" (FIM), which contains four items with answer options on a scale from 1-5. Answer responses are summed and averaged. Higher scores indicating higher feasibility. We will consider the intervention "feasible" if an average score of 4 or higher is obtained. |
1 week post-randomization
|
|
Number of Participants Retained
Délai: 1 week, 1 month, and 3 months post-randomization
|
We will determine if there are differences in retention rates between intervention groups. |
1 week, 1 month, and 3 months post-randomization
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of Questions About Knowledge Related to Quitting Smoking That Were Answered Correctly
Délai: 1 week
|
Questions about the impact of quitting smoking were asked to determine if there were numeric differences in the number of participants who answered each question correctly between intervention and control groups at 1-week follow-ups. Questions were true or false questions generated by the primary investigator. We calculated the number of participants who answered each of the three questions correctly. |
1 week
|
|
Number of Participants Who Made Quit Attempts and Achieved Smoking Abstinence at 1-week, 1-month, and 3-month Follow-ups
Délai: 1 week, 1 month, and 3 months post-randomization
|
We calculated the number of 24-hour quit attempts made by participants in each group at the 1-week, 3-month, and 6-month follow-ups. We also calculated the number of participants who reported past 7-day point prevalence abstinence at 1-week, 1-month, and 3-month follow-ups. |
1 week, 1 month, and 3 months post-randomization
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- Pro00133913
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .